Detail akcie Oncology Inst Rg online

Business Summary: The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Oncology Institute Inc revenues increased 10% to $104.4M. Net loss applicable to common stockholders decreased 1% to $16.1M. Revenues reflect Dispensary segment increase of 24% to $49.3M, Patient services segment increase of 1% to $53.1M. Lower net loss reflects Selling/General/Admin Expense decrease of 11% to $25.4M (expense).